Effect of hypothyroidism on insulin sensitivity and glucose tolerance in dogs

American Journal of Veterinary Research

Volumn 73, Issue 4, 2012, Pages 529-538

  Hofer Inteeworn, Natalie ^a,e   Panciera, David L ^a   Monroe, William E ^a   Saker, Korinn E ^a,f   Davies, Rebecca Hegstad ^b   Refsal, Kent R ^c   Kemnitz, Joseph W ^d  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GROWTH HORMONE; HYDROCORTISONE; SOMATOMEDIN C;

ABDOMINAL FAT; ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETES MELLITUS; DOG DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HYDROCORTISONE URINE LEVEL; HYPOTHYROIDISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NONHUMAN;

ABSORPTIOMETRY, PHOTON; ANIMALS; BLOOD GLUCOSE; BODY COMPOSITION; DOG DISEASES; DOGS; FEMALE; GLUCOSE INTOLERANCE; GROWTH HORMONE; HYDROCORTISONE; HYPOTHYROIDISM; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; IODINE RADIOISOTOPES;

ANIMALIA; CANIDAE; CANIS FAMILIARIS;

EID: 84859130072     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.73.4.529     Document Type: Article

References (74)

1. Ford SL, Nelson RW, Feldman EC, et al. Insulin resistance in three dogs with hypothyroidism and diabetes mellitus. J Am Vet Med Assoc 1993;202:1478-1480.
2. Dixon RM, Reid SW, Mooney CT. Epidemiological, clinical, haematological and biochemical characteristics of canine hypothyroidism. Vet Rec 1999;145:481-487.
3. Hess RS, Saunders HM, Van Winkle TJ, et al. Concurrent disorders in dogs with diabetes mellitus: 221 cases (1993-1998). J Am Vet Med Assoc 2000;217:1166-1173.
4. Renauld A, Pinto JE, Sverdlik RC, et al. Studies on the effect of thyroidectomy on the insulin response to hyperglycaemia in the dog. Acta Physiol Lat Am 1973;23:29-36.
5. Renauld A, Sverdlik RC, Andrade LL. Effects of hypothyroidism on serum immunoreactive insulin, free fatty acids and blood sugar in the dog as tested for oral glucose tolerance. Corrective effects of thyroxine therapy. Horm Metab Res 1974;6:137-141.
6. Renauld A, Sverdlik RC, Andrade LL, et al. Studies on the effect of thyroxine replacement therapy on the increased insulin response to hyperglycemia in the thyroidectomized dog. Horm Metab Res 1972;4:373-376.
7. Renauld A, Sverdlik RC, Garrido D. Blood sugar, serum insulin and serum free fatty acid responses to graded glucose pulses in hypothyroid dogs. Acta Diabetol Lat 1982;19:97-105.
8. Cettour-Rose P, Theander-Carrillo C, Asensio C, et al. Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusion. Diabetologia 2005;48:624-633.
9. Rochon C, Tauveron I, Dejax C, et al. Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism. Clin Sci (Lond) 2003;104:7-15.
10. Stanicka S, Vondra K, Pelikanova T, et al. Insulin sensitivity and counter-regulatory hormones in hypothyroidism and during thyroid hormone replacement therapy. Clin Chem Lab Med 2005;43:715-720.
11. Eigenmann JE, Eigenmann RY, Rijnberk A, et al. Progesteronecontrolled growth hormone overproduction and naturally occurring canine diabetes and acromegaly. Acta Endocrinol (Copenh) 1983;104:167-176.
12. Hurty CA, Flatland B. Feline acromegaly: a review of the syndrome. J Am Anim Hosp Assoc 2005;41:292-297.
13. Møller N, Jørgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 2009;30:152-177.
14. Diaz-Espineira MM, Galac S, Mol JA, et al. Thyrotropin-releasing hormone-induced growth hormone secretion in dogs with primary hypothyroidism. Domest Anim Endocrinol 2008;34:176-181.
15. Diaz-Espineira MM, Mol JA, Rijnberk A, et al. Adenohypophyseal function in dogs with primary hypothyroidism and nonthyroidal illness. J Vet Intern Med 2009;23:100-107.
16. Lee WM, Diaz-Espineira M, Mol JA, et al. Primary hypothyroidism in dogs is associated with elevated GH release. J Endocrinol 2001;168:59-66.
17. Ellmerer M, Hamilton-Wessler M, Kim SP, et al. Reduced access to insulin-sensitive tissues in dogs with obesity secondary to increased fat intake. Diabetes 2006;55:1769-1775.
18. Bergman RN, Prager R, Volund A, et al. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 1987;79:790-800.
19. Sauve F, Paradis M. Use of recombinant human thyroid-stimulating hormone for thyrotropin stimulation test in euthyroid dogs. Can Vet J 2000;41:215-219.
20. Tobin BL, Finegood DT. Reduced insulin secretion by repeated low doses of STZ impairs glucose effectiveness but does not induce insulin resistance in dogs. Diabetes 1993;42:474-483.
21. Pacini G, Bergman RN. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 1986;23:113-122.
22. Mari A, Ahren B, Pacini G. Assessment of insulin secretion in relation to insulin resistance. Curr Opin Clin Nutr Metab Care 2005;8:529-533.
23. Fracassi F, Gandini G, Diana A, et al. Acromegaly due to a somatroph adenoma in a dog. Domest Anim Endocrinol 2007;32:43-54.
24. Meij BP, Mol JA, Hazewinkel HA, et al. Assessment of a combined anterior pituitary function test in Beagle dogs: rapid sequential intravenous administration of four hypothalamic releasing hormones. Domest Anim Endocrinol 1996;13:161-170.
25. Secchi C, Berrini A, Gaggioli D, et al. Amino acid modifications in canine, equine and porcine pituitary growth hormones, identified by peptide-mass mapping. J Chromatogr B Biomed Sci Appl 2001;757:237-245.
26. Randolph JF, Toomey J, Center SA, et al. Use of the urine cortisol- to-creatinine ratio for monitoring dogs with pituitarydependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD). Am J Vet Res 1998;59:258-261.
27. Bergman RN, Ider YZ, Bowden CR, et al. Quantitative estimation of insulin sensitivity. Am J Physiol 1979;236:E667-E677.
28. Toffolo G, Bergman RN, Finegood DT, et al. Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog. Diabetes 1980;29:979-990.
29. Arner P, Bolinder J, Wennlund A, et al. Influence of thyroid hormone level on insulin action in human adipose tissue. Diabetes 1984;33:369-375.
30. Maratou E, Hadjidakis DJ, Kollias A, et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol 2009;160:785-790.
31. Pedersen O, Richelsen B, Bak J, et al. Characterization of the insulin resistance of glucose utilization in adipocytes from patients with hyper- and hypothyroidism. Acta Endocrinol (Copenh) 1988;119:228-234.
32. Dimitriadis G, Parry-Billings M, Bevan S, et al. The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats. Eur J Clin Invest 1997;27:475-483.
33. Ader M, Pacini G, Yang YJ, et al. Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal- model prediction with direct measurements. Diabetes 1985;34:1092-1103.
34. Ader M, Ni TC, Bergman RN. Glucose effectiveness assessed under dynamic and steady state conditions. Comparability of uptake versus production components. J Clin Invest 1997;99:1187-1199.
35. Best JD, Kahn SE, Ader M, et al. Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 1996;19:1018-1030.
36. Alzaid AA, Dinneen SF, Turk DJ, et al. Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans. J Clin Invest 1994;94:2341-2348.
37. Baron AD, Kolterman OG, Bell J, et al. Rates of noninsulin-mediated glucose uptake are elevated in type II diabetic subjects. J Clin Invest 1985;76:1782-1788.
38. Ahren B, Pacini G. Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol 2004;150:97-104.
39. Romero R, Casanova B, Pulido N, et al. Stimulation of glucose transport by thyroid hormone in 3T3-L1 adipocytes: increased abundance of GLUT1 and GLUT4 glucose transporter proteins. J Endocrinol 2000;164:187-195.
40. Weinstein SP, O'Boyle E, Haber RS. Thyroid hormone increases basal and insulin-stimulated glucose transport in skeletal muscle. The role of GLUT4 glucose transporter expression. Diabetes 1994;43:1185-1189.
41. Weinstein SP, Watts J, Haber RS. Thyroid hormone increases muscle/fat glucose transporter gene expression in rat skeletal muscle. Endocrinology 1991;129:455-464.
42. Torrance CJ, deVente JE, Jones JP, et al. Effects of thyroid hormone on GLUT4 glucose transporter gene expression and NIDDM in rats. Endocrinology 1997;138:1204-1214.
43. Richardson JM, Pessin JE. Identification of a skeletal musclespecific regulatory domain in the rat GLUT4/muscle-fat gene. J Biol Chem 1993;268:21021-21027.
44. Czech MP, Malbon CC, Kerman K, et al. Effect of thyroid status on insulin action in rat adipocytes and skeletal muscle. J Clin Invest 1980;66:574-582.
45. Mackowiak P, Ginalska E, Nowak-Strojec E, et al. The influence of hypo- and hyperthyreosis on insulin receptors and metabolism. Arch Physiol Biochem 1999;107:273-279.
46. Dimitriadis GD, Leighton B, Parry-Billings M, et al. Effects of hypothyroidism on the sensitivity of glycolysis and glycogen synthesis to insulin in the soleus muscle of the rat. Biochem J 1989;257:369-373.
47. Dimitriadis G, Mitrou P, Lambadiari V, et al. Insulin action in adipose tissue and muscle in hypothyroidism. J Clin Endocrinol Metab 2006;91:4930-4937.
48. Comte B, Vidal H, Laville M, et al. Influence of thyroid hormones on gluconeogenesis from glycerol in rat hepatocytes: a dose-response study. Metabolism 1990;39:259-263.
49. Huang MT, Lardy HA. Effects of thyroid states on the Cori cycle, glucose-alanine cycle, and futile cycling of glucose metabolism in rats. Arch Biochem Biophys 1981;209:41-51.
50. Okajima F, Ui M. Metabolism of glucose in hyper and hypothyroid rats in vivo. Relation of catecholamine actions to thyroid activity in controlling glucose turnover. Biochem J 1979;182:585-592.
51. Goldblatt MW. Insulin and the thyroidectomized rabbit. J Physiol 1936;86:46-60.
52. Handisurya A, Pacini G, Tura A, et al. Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH). Clin Endocrinol (Oxf) 2008;69:963-969.
53. Cobelli C, Pacini G, Toffolo G, et al. Estimation of insulin sensitivity and glucose clearance from minimal model: new insights from labeled IVGTT. Am J Physiol 1986;250:E591-E598.
54. Mittelman SD, Van Citters GW, Kim SP, et al. Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response. Diabetes 2000;49:2116-2125.
55. Dimitriadis G, Baker B, Marsh H, et al. Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans. Am J Physiol 1985;248:E593-E601.
56. Randin JP, Tappy L, Scazziga B, et al. Insulin sensitivity and exogenous insulin clearance in Graves' disease. Measurement by the glucose clamp technique and continuous indirect calorimetry. Diabetes 1986;35:178-181.
57. Finegood DT, Tzur D. Reduced glucose effectiveness associated with reduced insulin release: an artifact of the minimal-model method. Am J Physiol 1996;271:E485-E495.
58. Pacini G, Tonolo G, Sambataro M, et al. Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified FSIGT. Am J Physiol 1998;274:E592-E599.
59. Brehm A, Thomaseth K, Bernroider E, et al. The role of endocrine counterregulation for estimating insulin sensitivity from intravenous glucose tolerance tests. J Clin Endocrinol Metab 2006;91:2272-2278.
60. Panciera DL. Hypothyroidism in dogs: 66 cases (1987-1992). J Am Vet Med Assoc 1994;204:761-767.
61. Mittelman SD, Van Citters GW, Kirkman EL, et al. Extreme insulin resistance of the central adipose depot in vivo. Diabetes 2002;51:755-761.
62. Kong AP, Chan NN, Chan JC. The role of adipocytokines and neurohormonal dysregulation in metabolic syndrome. Curr Diabetes Rev 2006;2:397-407.
63. Mazaki-Tovi M, Feuermann Y, Segev G, et al. Increased serum leptin and insulin concentrations in canine hypothyroidism. Vet J 2008;183:109-114.
64. Chernausek SD, Turner R. Attenuation of spontaneous, nocturnal growth hormone secretion in children with hypothyroidism and its correlation with plasma insulin-like growth factor I concentrations. J Pediatr 1989;114:968-972.
65. Hanew K, Utsumi A, Sugawara A, et al. Enhanced plasma GH responses to simultaneous administration of TRH and GHRH in patients with primary hypothyroidism. Endocr J 1995;42:43-47.
66. Valcavi R, Dieguez C, Preece M, et al. Effect of thyroxine replacement therapy on plasma insulin-like growth factor 1 levels and growth hormone responses to growth hormone releasing factor in hypothyroid patients. Clin Endocrinol (Oxf) 1987;27:85-90.
67. Akin F, Yaylali GF, Turgut S, et al. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction. Growth Horm IGF Res 2009;19:252-255.
68. Miell JP, Zini M, Quin JD, et al. Reversible effects of cessation and recommencement of thyroxine treatment on insulin-like growth factors (IGFs) and IGF-binding proteins in patients with total thyroidectomy. J Clin Endocrinol Metab 1994;79:1507-1512.
69. Schmid C, Zwimpfer C, Brandle M, et al. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism. Clin Endocrinol (Oxf) 2006;65:706-711.
70. Burstein PJ, Draznin B, Johnson CJ, et al. The effect of hypothyroidism on growth, serum growth hormone, the growth hormone- dependent somatomedin, insulin-like growth factor, and its carrier protein in rats. Endocrinology 1979;104:1107-1111.
71. Ramos S, Goya L, Alvarez C, et al. Effect of thyroxine administration on the IGF/IGF binding protein system in neonatal and adult thyroidectomized rats. J Endocrinol 2001;169:111-122.
72. Hoshiro M, Ohno Y, Masaki H, et al. Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients. Clin Endocrinol (Oxf) 2006;64:37-45.
73. Iranmanesh A, Lizarralde G, Johnson ML, et al. Dynamics of 24-hour endogenous cortisol secretion and clearance in primary hypothyroidism assessed before and after partial thyroid hormone replacement. J Clin Endocrinol Metab 1990;70:155-161.
74. Vantyghem MC, Ghulam A, Hober C, et al. Urinary cortisol metabolites in the assessment of peripheral thyroid hormone action: overt and subclinical hypothyroidism. J Endocrinol Invest 1998;21:219-225.